1
|
Yu D, Guo R, Zhu L. The risk and prognostic factors for lung metastases in oral squamous cell carcinoma: A population-based analysis of the SEER database. JOURNAL OF STOMATOLOGY, ORAL AND MAXILLOFACIAL SURGERY 2024; 125:101713. [PMID: 38040119 DOI: 10.1016/j.jormas.2023.101713] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Received: 11/14/2023] [Accepted: 11/24/2023] [Indexed: 12/03/2023]
Abstract
PURPOSE This study aimed to describe the risk and prognostic factors associated with lung metastases among oral squamous cell carcinoma (OSCC) patients, further to establish a nomogram model to predict the risk of lung metastases. METHODS Data on OSCC patients was retrieved from the Surveillance, Epidemiology, and End Results (SEER) database between 2010 and 2019. Univariable and multivariable logistic and Cox regression models were used to explore the risk factors for developing lung metastases, further the predictive nomogram was constructed. RESULTS 19, 606 OSCC patients meets the inclusion criteria and were enrolled into this study. Of which, 221 cases have lung metastases at initial diagnosis. Multivariate logistic regression analysis indicated race, T stage, N stage as well as bone metastases, liver metastases were independently associated the development of lung metastases. The diagnostic nomogram for developing lung metastases was constructed, the c-index for this model was 0.830 (0.804-0.856). Both the ROC curve and calibration curves revealed accurate predictability. DCA curve displayed the established nomogram model had good clinical applicability for the prediction of lung metastases. The median OS of OSCC patients with lung metastases was 7.0 months (6.0-9.0), and the 6-months, 12-months, 24-month OS rates were 54.5%, 30.9%, 17.7%, respectively. The multivariate Cox analysis showed that chemotherapy and liver metastases were independently associated with both OS and CSS. CONCLUSION This study determined the risk and prognostic factors for lung metastases among OSCC patients and the established nomogram had good calibration and discrimination for predicting lung metastases.
Collapse
Affiliation(s)
- Dan Yu
- Department of General Medicine, Changzheng Hospital, The Naval Military Medical University, Shanghai, China
| | - Rong Guo
- Department of General Medicine, Changzheng Hospital, The Naval Military Medical University, Shanghai, China
| | - Lei Zhu
- Department of Stomatology, Changzheng Hospital, The Naval Military Medical University, Shanghai, China.
| |
Collapse
|
2
|
Qu W, Qin Z, Cui L, Yuan S, Yao N, Ma J, Lu J, Wang J, Wang M, Yao Y. Diagnostic and prognostic nomograms for laryngeal carcinoma patients with lung metastasis: a SEER-based study. Eur Arch Otorhinolaryngol 2024; 281:3071-3082. [PMID: 38584217 DOI: 10.1007/s00405-024-08608-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2023] [Accepted: 03/10/2024] [Indexed: 04/09/2024]
Abstract
PURPOSE To establish two nomograms to quantify the risk of lung metastasis (LM) in laryngeal carcinoma (LC) and predict the overall survival of LC patients with LM. METHODS Totally 9515 LC patients diagnosed histologically from 2000 to 2019 were collected from the Surveillance, Epidemiology, and End Results database. The independent diagnostic factors for LM in LC patients and prognostic factors for LC patients with LM were identified by logistic and Cox regression analysis, respectively. Nomograms were established based on regression coefficients and evaluated by receiver operating characteristic curve, calibration curves, and decision curve analysis. RESULTS Patients with supraglottis, higher pathological grade, higher N stage, and distant metastasis (bone, brain, or liver) were more likely to have LM (P < 0.05). Chemotherapy, surgery and radiotherapy were independent factors of the overall survival of LC patients with LM (P < 0.05). The area under curve of diagnostic nomogram were 0.834 and 0.816 in the training and validation cohort respectively. For the prognostic nomogram, the area under curves of 1-, 2-, and 3-years were 0.735, 0.734, and 0.709 in the training cohort and 0.705, 0.803, and 0.809 in the validation cohort. The calibration curves and decision curve analysis indicated good performance of the nomograms. CONCLUSION Distant metastasis (bone, brain, or liver) and N stage should be considered for prediction of LM in LC patients. Chemotherapy is the most significant influencing prognostic factor improving the survival of LC patients with LM. Two nomograms may benefit for providing better precautionary measures and treatment decision.
Collapse
Affiliation(s)
- Wanxi Qu
- Graduate School of Xuzhou Medical University, Xuzhou, 221000, Jiangsu, China
| | - Zhaohui Qin
- Research Center for Medical and Health Emergency Rescue, Xuzhou Medical University, Xuzhou, 221000, Jiangsu, China
| | - Li Cui
- Graduate School of Xuzhou Medical University, Xuzhou, 221000, Jiangsu, China
| | - Shiwang Yuan
- Graduate School of Xuzhou Medical University, Xuzhou, 221000, Jiangsu, China
| | - Nan Yao
- Graduate School of Xuzhou Medical University, Xuzhou, 221000, Jiangsu, China
| | - Ji Ma
- Graduate School of Xuzhou Medical University, Xuzhou, 221000, Jiangsu, China
| | - Jiaying Lu
- Graduate School of Xuzhou Medical University, Xuzhou, 221000, Jiangsu, China
| | - Jiang Wang
- Graduate School of Xuzhou Medical University, Xuzhou, 221000, Jiangsu, China
| | - Minhan Wang
- Graduate School of Xuzhou Medical University, Xuzhou, 221000, Jiangsu, China
| | - Yuanhu Yao
- Graduate School of Xuzhou Medical University, Xuzhou, 221000, Jiangsu, China.
- Department of Radiation Oncology, The Affiliated Wuxi People's Hospital of Nanjing Medical University, Wuxi, 214023, Jiangsu, China.
| |
Collapse
|
3
|
Park H, Han S, Jeong WJ, Jung YH, Sung MW, Ahn SH. Oncological Outcomes after Pulmonary Metastasectomy for Head and Neck Squamous-Cell Carcinoma and Adenoid Cystic Carcinoma. ORL J Otorhinolaryngol Relat Spec 2022; 84:387-395. [PMID: 35344950 DOI: 10.1159/000522111] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/28/2020] [Accepted: 01/17/2022] [Indexed: 11/19/2022]
Abstract
INTRODUCTION Pulmonary metastatic head and neck cancer has a poor prognosis. Pulmonary metastasectomy has been performed but only in carefully selected patients. The aim of this study was to examine the clinical characteristics and oncological follow-up of patients who underwent pulmonary metastasectomy. METHODS Data of 54 patients with squamous-cell carcinoma (SCC) or adenoid cystic carcinoma (ACC) who underwent metastasectomy between 2003 and 2019 at two tertiary referral centers were retrospectively reviewed. RESULTS The 3-year and 5-year disease-free survival rates after metastasectomy were 49.9% and 39.9% for SCC and 38.9% and 32.4% for ACC, respectively. Univariate analysis revealed that a disease-free interval (DFI) less than 14 months and R1 resection (hazard ratio [HR] [95% confidence interval]: 2.95 [0.77-5.62], 4.64 [0.99-21.65], respectively) were risk factors for recurrence in SCC and that a high T stage (HR: 5.24 [1.22-22.58]) was a risk factor in ACC. In SCC, a DFI less than 14 months and R1 resection (hazard ratio: 6.35 [1.36-29.54], 12.79 [1.53-106.95], respectively) were risk factors in a multivariate analysis. CONCLUSION Pulmonary metastasectomy had a fair effect on head and neck SCC and ACC, and the prognosis was better in SCC patients with a DFI greater than 14 months.
Collapse
Affiliation(s)
- Hanaro Park
- Department of Otorhinolaryngology-Head & Neck Surgery, Samsung Changwon Hospital, Sungkyunkwan University School of Medicine, Changwon, Republic of Korea,
| | - Sungjun Han
- Department of Otorhinolaryngology-Head and Neck Surgery, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Republic of Korea
| | - Woo-Jin Jeong
- Department of Otorhinolaryngology-Head & Neck Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea
| | - Young Ho Jung
- Department of Otorhinolaryngology-Head & Neck Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Republic of Korea
| | - Myung-Whun Sung
- Department of Otorhinolaryngology-Head & Neck Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea
| | - Soon-Hyun Ahn
- Department of Otorhinolaryngology-Head & Neck Surgery, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Republic of Korea
| |
Collapse
|
4
|
Yang W, Mei X, Zhou Y, Su R, Lei W, Zheng S, Zhu R, Guo L, Tao Y, Su Y, Li J, Ding C, Zou S, Li X, Hu H. Risk factors and survival outcomes of laryngeal squamous cell carcinoma patients with lung metastasis: A population-based study. Auris Nasus Larynx 2020; 48:723-730. [PMID: 33358379 DOI: 10.1016/j.anl.2020.11.009] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/28/2020] [Revised: 11/04/2020] [Accepted: 11/18/2020] [Indexed: 10/22/2022]
Abstract
OBJECTIVE It remains elusive which factors may influence the morbidity and mortality of lung metastasis (LM) in Laryngeal Squamous Cell Carcinoma (LSCC) patients. The aim of the present study was to investigate factors influencing LM and the survival outcomes of LSCC patients with LM. METHODS We identified 10,935 patients with LSCC from 2010 to 2014 using the Surveillance, Epidemiology and End Results database. Multivariate logistic regression analysis was used to determine the factors associated with the presence of LM. Multivariate cox regression analysis was used to identify covariates associated with increased all-cause mortality in patients with LM. RESULTS Among 10,935 patients with LSCC, 232 (2.12%) patients had LM. The median survival time of patients with LM was 8 months, and 8.37% of patients survived after 3 years. Patients with age ≥ 60 years old, unmarried status, supraglottis, overlapping lesion of larynx, subglottis, pathological grade III, T4 stage, N1 stage, N2 stage, N3 stage and bone, brain or liver metastases were more likely to have LM. Survival analysis showed that chemotherapy and radiotherapy suggested better survival of LSCC patients with LM while pathological grade IV was associated with an increased all-cause mortality. CONCLUSION The incidence of LSCC patients with LM varied by age, married status, and tumor subtypes. LSCC patients with LM had poor survival, and only 8.37% of patients survived after 3 years. However, chemotherapy and radiotherapy were found as independent favorable prognostic factors for survival.
Collapse
Affiliation(s)
- Weiqiang Yang
- Department of Otorhinolaryngology, Hearing and Balance Function Medical Engineering Laboratory, Peking University Shenzhen Hospital, Shenzhen 518036, China.
| | - Xueshuang Mei
- Department of Otorhinolaryngology, Hearing and Balance Function Medical Engineering Laboratory, Peking University Shenzhen Hospital, Shenzhen 518036, China.
| | - Yaqi Zhou
- Department of Otorhinolaryngology, Hearing and Balance Function Medical Engineering Laboratory, Peking University Shenzhen Hospital, Shenzhen 518036, China.
| | - Rongfei Su
- Department of Otorhinolaryngology, Hearing and Balance Function Medical Engineering Laboratory, Peking University Shenzhen Hospital, Shenzhen 518036, China.
| | - Wenbin Lei
- Otorhinolaryngology Hospital, Institute of Otolaryngology, Guangdong Provincial Key Laboratory, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou 510080, China.
| | - Shixin Zheng
- Department of Otorhinolaryngology, Hearing and Balance Function Medical Engineering Laboratory, Peking University Shenzhen Hospital, Shenzhen 518036, China.
| | - Rufei Zhu
- Department of Otorhinolaryngology, Hearing and Balance Function Medical Engineering Laboratory, Peking University Shenzhen Hospital, Shenzhen 518036, China.
| | - Lianrong Guo
- Department of Otorhinolaryngology, Hearing and Balance Function Medical Engineering Laboratory, Peking University Shenzhen Hospital, Shenzhen 518036, China.
| | - Yuan Tao
- Department of Otorhinolaryngology, Hearing and Balance Function Medical Engineering Laboratory, Peking University Shenzhen Hospital, Shenzhen 518036, China.
| | - Yongjin Su
- Department of Otorhinolaryngology, Hearing and Balance Function Medical Engineering Laboratory, Peking University Shenzhen Hospital, Shenzhen 518036, China.
| | - Jianyu Li
- Department of Otorhinolaryngology, Hearing and Balance Function Medical Engineering Laboratory, Peking University Shenzhen Hospital, Shenzhen 518036, China.
| | - Chuchu Ding
- Department of Otorhinolaryngology, Hearing and Balance Function Medical Engineering Laboratory, Peking University Shenzhen Hospital, Shenzhen 518036, China.
| | - Songfeng Zou
- Department of Otorhinolaryngology, Hearing and Balance Function Medical Engineering Laboratory, Peking University Shenzhen Hospital, Shenzhen 518036, China.
| | - Xiaoling Li
- Community Health Service Management Center, The Eighth Affiliated Hospital of Sun Yat-sen University, Shenzhen 518033, China.
| | - Hongyi Hu
- Department of Otorhinolaryngology, Hearing and Balance Function Medical Engineering Laboratory, Peking University Shenzhen Hospital, Shenzhen 518036, China.
| |
Collapse
|
5
|
Ichinose J, Shinozaki-Ushiku A, Nagayama K, Nitadori JI, Anraku M, Fukayama M, Nakajima J, Takai D. Immunohistochemical pattern analysis of squamous cell carcinoma: Lung primary and metastatic tumors of head and neck. Lung Cancer 2016; 100:96-101. [PMID: 27597287 DOI: 10.1016/j.lungcan.2016.08.003] [Citation(s) in RCA: 10] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/22/2016] [Revised: 08/01/2016] [Accepted: 08/09/2016] [Indexed: 12/31/2022]
Abstract
OBJECTIVES This study aimed to develop an immunohistochemical (IHC) diagnostic algorithm for primary lung squamous cell carcinoma (LSCC) and pulmonary metastasis of head and neck SCC (HNSCC). MATERIALS AND METHODS We selected three antibodies (CK19, MMP3, and PI3) from a web-based gene expression database and an IHC analysis available online. We developed an IHC diagnostic algorithm using tissue microarrays from 39 LSCCs and 48 HNSCCs as the training set. It was validated using whole tumor sections of 32 LSCCs and 23 HNSCCs. The algorithm was applied to 28 cases with a history of HNSCC and who underwent resection of pulmonary squamous cell tumors. RESULTS The sensitivity, specificity, and accuracy of the algorithm were 90%, 62%, and 77%, respectively, in the training set and 96%, 44%, and 65%, respectively, in the validation set. Twenty-three of 28 SCCs were diagnosed as metastasis of HNSCC; the remaining five tumors were diagnosed as LSCC. Among the patients in the HNSCC group, 18 developed postoperative recurrence and 11 died of the disease, whereas only one patient in the LSCC group had recurrence. Compared with the LSCC group, the HNSCC group had poorer prognosis (P=0.07). IHC diagnosis coincided with the retrospective diagnosis in 22 (79%) of the 28 patients (sensitivity, 95%; specificity, 44%). CONCLUSION The IHC diagnostic algorithm may be clinically useful for distinguishing between LSCC and pulmonary metastasis of HNSCC.
Collapse
Affiliation(s)
- Junji Ichinose
- Department of Thoracic Surgery, University of Tokyo Hospital, Tokyo, Japan.
| | | | - Kazuhiro Nagayama
- Department of Thoracic Surgery, University of Tokyo Hospital, Tokyo, Japan
| | - Jun-Ichi Nitadori
- Department of Thoracic Surgery, University of Tokyo Hospital, Tokyo, Japan
| | - Masaki Anraku
- Department of Thoracic Surgery, University of Tokyo Hospital, Tokyo, Japan
| | - Masashi Fukayama
- Department of Pathology, University of Tokyo Hospital, Tokyo, Japan
| | - Jun Nakajima
- Department of Thoracic Surgery, University of Tokyo Hospital, Tokyo, Japan
| | - Daiya Takai
- Department of Clinical Laboratory, University of Tokyo Hospital, Tokyo, Japan
| |
Collapse
|
6
|
Ichinose J, Shinozaki-Ushiku A, Takai D, Fukayama M, Nakajima J. Differential diagnosis between primary lung squamous cell carcinoma and pulmonary metastasis of head and neck squamous cell carcinoma. Expert Rev Anticancer Ther 2016; 16:403-10. [PMID: 26813704 DOI: 10.1586/14737140.2016.1147352] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/21/2022]
Abstract
Differentiation between lung squamous cell carcinoma and pulmonary metastasis of head and neck squamous cell carcinoma is clinically important because the prognoses and therapeutic options are considerably different. However, the clinical, pathological, and immunohistochemical diagnostic methods have not yet been fully established. Although various molecular methods have been developed, they have not yet been practically applied. A combined approach involving molecular and immunohistochemical analysis, such as one that uses antibodies selected on the basis of comprehensive genetic analysis results, may be effective. We suggest a new diagnostic criteria using the clinical characteristics and the result of immunohistochemical analysis. However, there are two underlying problems in the development of new diagnostic methods: tumor heterogeneity and determination of the diagnostic accuracy.
Collapse
Affiliation(s)
- Junji Ichinose
- a Department of Thoracic Surgery , the University of Tokyo Hospital , Tokyo , Japan
| | | | - Daiya Takai
- c Department of Clinical Laboratory , the University of Tokyo Hospital , Tokyo , Japan
| | - Masashi Fukayama
- b Department of Pathology , the University of Tokyo Hospital , Tokyo , Japan
| | - Jun Nakajima
- a Department of Thoracic Surgery , the University of Tokyo Hospital , Tokyo , Japan
| |
Collapse
|
7
|
Survival outcomes after surgical resection of pulmonary metastases of head and neck tumours. The Journal of Laryngology & Otology 2016; 130:291-5. [PMID: 26837665 DOI: 10.1017/s0022215116000050] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Abstract
BACKGROUND There is limited information available regarding the benefits and outcomes of resection of pulmonary metastases arising from head and neck cancers. METHODS A retrospective review was performed of 21 patients who underwent resection of pulmonary metastases of primary head and neck malignancies at Hamamatsu University Hospital. Clinical staging, treatment methods, pathological subtype (particularly squamous cell carcinoma), disease-free interval and overall survival were evaluated. RESULTS The 5- and 10-year overall survival rates of the study participants were 67.0 per cent and 55.0 per cent, respectively, as determined by the Kaplan-Meier method. The prognosis for patients with a disease-free interval of less than 24 months was poor compared to those with a disease-free interval of greater than 24 months (p = 0.0234). CONCLUSION Patients with short disease-free intervals, and possibly those who are older than 60 years, should be categorised as having severe disease. However, pulmonary metastases from head and neck malignancies are potentially curable by surgical resection.
Collapse
|
8
|
Shiono S, Kawamura M, Sato T, Okumura S, Nakajima J, Yoshino I, Ikeda N, Horio H, Akiyama H, Kobayashi K. Pulmonary Metastasectomy for Pulmonary Metastases of Head and Neck Squamous Cell Carcinomas. Ann Thorac Surg 2009; 88:856-60. [DOI: 10.1016/j.athoracsur.2009.04.040] [Citation(s) in RCA: 95] [Impact Index Per Article: 6.3] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 02/12/2009] [Revised: 04/09/2009] [Accepted: 04/14/2009] [Indexed: 01/31/2023]
|